Project Grant R03DK144289
- Federal Grant Award Summary The University of Virginia received a $797,878 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective February 24, 2026, with a completion date of January 31, 2030. The award funds basic biomedical research investigating the pathogenesis of concentric arterial and arteriolar hypertrophy (CAAH) in kidney arterioles, a...
- Federal Grant Award Summary The University of Virginia received a $717,030 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective May 1, 2026, through March 31, 2031. This research grant funds the development and application of molecular connectomics techniques to elucidate neural circuits controlling body weight and energy homeostasis in the...
- Federal Project Grant Award Summary The University of Virginia received a $244,572 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective June 3, 2025, with a completion date of December 31, 2026. The award supports research titled "The Reninness Score: Integrative Analysis of Multi-Omic Data to Define Renin Cell Identity," which focuses...
- Federal Grant Award Summary The University of Virginia received a $782,459 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective March 1, 2026, with a completion date of February 28, 2031. The award supports basic and clinical biomedical research examining the mechanisms by which obesity exacerbates cardiovascular disease risk in individuals with...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded the University of Pennsylvania a $798,039 Project Grant effective March 1, 2026, through January 31, 2030, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). This research initiative will deliver computational modeling and experimental research aimed at understanding self-organization mechanisms in the intestinal epithelium, specifically...
- Federal Grant Award Summary The University of Vermont received a $320,778 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective September 15, 2025, through August 31, 2028. This award funds basic biomedical research investigating the intersection of pituitary adenylate cyclase activating peptide (PACAP)/PAC1 receptor signaling and...
- Federal Grant Award Summary The University of Texas Health Science Center at Houston received a $2.62 million Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) awarded September 8, 2025, with completion scheduled for September 7, 2029. The award supports a five-year research initiative to advance intestinal tissue engineering as a potential cure for pediatric...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded the University of Virginia a $1.44 million Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) for the period May 1, 2026 through April 30, 2029. This ancillary research project will utilize data and peripheral blood mononuclear cell (PBMC) samples from the Environmental Determinants of Diabetes in the Young (TEDDY) longitudinal...
- Federal Project Grant Award Summary Virginia Commonwealth University received a $177,350 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective September 1, 2025, through August 31, 2030. The project develops objective analytical tools and predictive methodologies to advance sacral neuromodulation (SNM) treatment optimization for overactive bladder...
- Federal Project Grant Award Summary The University of Vermont & State Agricultural College received a $898,265 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective July 1, 2025, through April 30, 2030. This award funds biomedical research aimed at elucidating the mechanisms by which tryptophan-producing bacteria modulate serotonin...
The University of Virginia received a $121,125 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) effective May 1, 2026, through April 30, 2028. The award funds development of an engineered three-dimensional microfluidic co-culture system designed to investigate the effects of biomechanical forces on enteric neurons and glia. This research addresses chronic idiopathic constipation and Hirschsprung disease by creating an in vitro model that isolates and measures the impact of specific mechanical forces—stretch and stiffness—on enteric nervous system function, thereby enabling controlled investigation that cannot be readily achieved through in vivo models alone. The project builds upon preliminary findings demonstrating that altered tissue mechanical properties in chronically distended intestines activate the mechanoreceptor PIEZO1, resulting in changes to enteric neuronal phenotype and function. By developing novel methods and technology to study biomechanical force responses in isolated cell populations, the research aims to establish foundational knowledge applicable to multiple gastrointestinal disorders and potentially identify new therapeutic targets for conditions where current surgical interventions such as intestinal resection or diversion represent limited treatment options for pediatric patients.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $121.1k | 4/27/26 |